Evidence map›Paper›PMID 42492513›Full record

ArticleStem cell reports2026

High and intermittent hydrostatic pressure promotes maturation of engineered cardiac tissues derived from human pluripotent stem cells.

Wusiman Maihemuti, Kozue Murata, Takahiro Jimba, Jun Iida, Keisuke Hakamada, Akane Sakaguchi, Mosha Abulaiti, Yuichi Saito, Laura Yuriko González-Teshima, Satoshi Takatori and 6 more

Abstract read
In one paragraph

Article in Stem cell reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Wusiman MaihemutiClinical Translational Research Program, RIKEN Center for Biosystems Dynamics Research, 2-2-3 Minatojimaminami-cho, Chuo-ku, Kobe 650-0047, Japan; Department of Cardiovascular Surgery, Graduate School of Medicine, Kyoto University, 54 Kawara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan.
Kozue MurataClinical Translational Research Program, RIKEN Center for Biosystems Dynamics Research, 2-2-3 Minatojimaminami-cho, Chuo-ku, Kobe 650-0047, Japan; Department of Cardiovascular Surgery, Graduate School of Medicine, Kyoto University, 54 Kawara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan.
Takahiro JimbaDepartment of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
Jun IidaClinical Translational Research Program, RIKEN Center for Biosystems Dynamics Research, 2-2-3 Minatojimaminami-cho, Chuo-ku, Kobe 650-0047, Japan; Department of Cardiovascular Surgery, Graduate School of Medicine, Kyoto University, 54 Kawara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan.
Keisuke HakamadaDepartment of Cardiovascular Surgery, Graduate School of Medicine, Kyoto University, 54 Kawara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan.
Akane SakaguchiLaboratory for Heart Regeneration, RIKEN Center for Biosystems Dynamics Research, 2-2-3 Minatojimaminami-cho, Chuo-ku, Kobe 650-0047, Japan.
Mosha AbulaitiClinical Translational Research Program, RIKEN Center for Biosystems Dynamics Research, 2-2-3 Minatojimaminami-cho, Chuo-ku, Kobe 650-0047, Japan.
Yuichi SaitoLaboratory for Heart Regeneration, RIKEN Center for Biosystems Dynamics Research, 2-2-3 Minatojimaminami-cho, Chuo-ku, Kobe 650-0047, Japan.
Laura Yuriko González-TeshimaClinical Translational Research Program, RIKEN Center for Biosystems Dynamics Research, 2-2-3 Minatojimaminami-cho, Chuo-ku, Kobe 650-0047, Japan; Department of Cardiovascular Surgery, Graduate School of Medicine, Kyoto University, 54 Kawara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan.
Satoshi TakatoriFaculty of Life and Medical Sciences, Doshisha University, 1-3 Tatara Miyakodani, Kyotanabe, Kyoto 610-0394, Japan.
Takahiro KenmotsuFaculty of Life and Medical Sciences, Doshisha University, 1-3 Tatara Miyakodani, Kyotanabe, Kyoto 610-0394, Japan.
Kenichi YoshikawaFaculty of Life and Medical Sciences, Doshisha University, 1-3 Tatara Miyakodani, Kyotanabe, Kyoto 610-0394, Japan.
Kenji MinatoyaDepartment of Cardiovascular Surgery, Graduate School of Medicine, Kyoto University, 54 Kawara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan.
Seitaro NomuraDepartment of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
Wataru KimuraLaboratory for Heart Regeneration, RIKEN Center for Biosystems Dynamics Research, 2-2-3 Minatojimaminami-cho, Chuo-ku, Kobe 650-0047, Japan.
Hidetoshi MasumotoClinical Translational Research Program, RIKEN Center for Biosystems Dynamics Research, 2-2-3 Minatojimaminami-cho, Chuo-ku, Kobe 650-0047, Japan; Department of Cardiovascular Surgery, Graduate School of Medicine, Kyoto University, 54 Kawara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan. Electronic address: hidetoshi.masumoto@riken.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The immaturity of human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) and engineered cardiac tissues (ECTs) limits their use in regenerative therapies. Ventricular loading pressure plays a vital role in cardiac repair, prompting the hypothesis that hydrostatic pressure could enhance ECT maturation. ECTs were created by co-culturing hPSC-derived cardiovascular cells with extracellular matrix proteins and subjecting them to intermittent hydrostatic pressure (1 h/day at 50 kPa for 3 days after 2 weeks of pre-culture). This protocol improved cardiomyocyte alignment, mitochondrial content, and metabolic and functional maturation, evidenced by enhanced contractility, calcium flux, and single-cell RNA sequencing. Endothelial cells were critical for these effects, as their absence prevented maturation. Hydrostatic pressure combined with dynamic culture also promoted vascular network formation. Transplanted trained ECTs significantly improved ejection fraction in a rat myocardial infarction model. These findings demonstrate the potential of hydrostatic pressure training to advance ECT maturation and therapeutic application.

Indexed as

Myocytes, CardiacPluripotent Stem CellsTissue EngineeringAnimalsCell DifferentiationEndothelial CellsHumansHydrostatic PressureMyocardiumRatscardiac maturationcardiac regenerationcardiomyocytesendothelial cellsengineered cardiac tissueshuman pluripotent stem cellshydrostatic pressuremechanotransduction

Identifiers

PMID42492513
PMCPMC13476875

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.